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1. Introduction 
The peptide chain elongation factor EF-Tu from 
Escherichia coli is an allosteric protein with multiple 
activities in the bacterial cell. Besides its function in 
protein synthesis [ 1,2], it acts as a subunit of the 
enzyme Q/3 RNA replicase [3]. Its extremely high intra- 
cellular abundance [4,5] and its peripheral association 
with the inner membrane of the E. eoli cell [4] have 
led to speculations about an additional structural role 
for this remarkable protein [6,7]. 
Two unlinked genes coding for EF-Tu have been 
identified on the E. coli chromosome [8-10]. One 
designated tufA maps at 72 rain, the other, designated 
tufB, at 88 min. Their nucleotide sequences have 
recently been elucidated [ 11,12]. The primary struc- 
tures of the corresponding gene products designated 
EF-TuA and EF-TuB, respectively, were thus found to 
be identical, except for the C-terminal amino acid 
residue (Gly or Ser). This is in accordance with the 
directly determined primary structure of the mixture 
of the two proteins [13,14]. 
EF-Tu interacts with a great number of ligands and 
in some cases this interaction has been correlated with 
conformational changes of the polypeptide chain 
[2,15,16]. To study the relation between the struc- 
ture and function of this multifunctional nd allosteric 
protein, we have isolated a number ofE. eoli mutants 
with an altered EF-Tu. We took advantage of the fact 
that the antibiotic kirromycin binds to the factor in 
an 1:1 molar ratio [17]. This binding to EF-Tu • GDP 
induces an EF-Tu • GTP-like conformation which pre- 
vents the release of the factor from the ribosome, thus 
blocking protein synthesis [ 15,18,19]. 
Expression of a kirromycin-resistant phenotype 
requires the alteration f both tufA and tufB [ 10,20, 
21 ]. Inactivation of tufB by insertion of bacteriophage 
Mu or by an amber mutation enabled us to isolate 
single gene products derived from either wild-type 
tufA (designated EF-TuAs) or kirromycin resistant 
tufA (designated EF-TuAR). Both protein species 
have the same relative molecular mass (Mr) and isoelec- 
tric point [22]. EF-TuA R has a strongly reduced affin- 
ity for kirromycin, but its function in polypeptide 
synthesis appeared to be normal [ 17,22,23 ]. On the 
other hand, if EF-TuA R replaces its wild-type counter- 
part in 033 replicase the enzyme is rapidly inactivated 
and displays an apparent increase in template specific- 
ity [24]. 
Here we show that Ala-375 of EF-TuA S is substi- 
tuted by Thr in EF-TuA R. The importance of this sub- 
stitution for structure and function of the enzyme is 
discussed. 
2. Materials and methods 
2.1. Materials 
EF-TuAsB S (wild-type EF-Tu, a mixture of tufA 
and tufB gene products) was isolated from E. coli B, 
and EF-TuA R (kirromycin-resistant tufA gene product) 
from the E. coli mutant strain LBE 2045 [10] as in 
[25]. All other materials were the same as used in [26]. 
2.2. Methods 
EF-Tu was digested with trypsin at an enzyme/sub- 
strate ratio of 1/100 (w/w) in 0.1 M NH4HCO3, pH 7.8 
at 37°C for 4 h. After lyophilization, fingerprint anal- 
ysis of the mixture of peptides was performed as in 
[26]. Amino acid analysis of the eluted peptides and 
their sequence determination by means of the dansyl- 
Edman degradation procedure were done as in [27]. 
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3. Results 
3.1. Amino acid substitution at position 375 
Fingerprint analysis of the tryptic peptides obtained 
from a wild-type mixture of EF-TuA S and EF-TuB S 
and from mutant EF-TuA R are presented in fig.1. 
Electrophoretic runs were performed at pH 3.5 (upper 
part) and at pH 6.5 (lower part). After fluorescamine 
staining all the visible peptides were eluted for amino 
acid analysis. This enabled their assignment in the pep- 
tide chain, according to the primary structure in [14]. 
About 70% of all the amino acids of the EF-Tu mole- 
• ~ > Chromatography ~romatography 
Fig.1. Fingerprint analysis of the tryptic peptides of wild-type EF-Tu(AsBs) and kirromycin resistant EF-Tu(AR). About 2 mg 
protein was digested with trypsin and spotted on Whatman 3 MM paper. After descending chromatography with butanol/pyridine] 
acetic acid/water (15110/3/12, by vol.) the upper two papers were subjected to electrophoresis at pH 3.5 (pyridine/acetic a id• 
water, 1/10/90, by vol.) and the lower two to electrophoresis at pH 6.5 (pyridine/acetic a id/water, 25/1/225, by vol.). On the 
left side of the origin, 20 nmol Phe and Lys were spotted as markers during the electrophoresis.The peptides were visualized with 
fluorescamine. The numbers indicated in the figure refer to the numbering of tryptic peptides in [14]; T9, positions 45-56;  T10, 
45-58;  T11,57-58;  T46, 374-378; T49,390-393.  ( - )  = cathode; (+) = anode. 
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Table 1 
Amino acid compositions of  the tryptic- peptide T46 
(positions 374-377)  from EF-TuAsB S and EF-TuA R 
Amino EF-TuAsB S EF-TuA R 
acid b 
I a II a I a II a 
Thr 1.1 0.9 
Ala 0.9 1.1 
lie 1.0 0.8 0.9 0.9 
Phe c 0.4 0.5 0.4 0.4 
Arg 1.1 1.1 1.0 1.2 
Peptide 
yield (%) 20 15 20 24 
a 1 and II indicate isolation from a fingerprint with electro- 
phoresis in the second dimension at pH 3.5 and 6.5, respec- 
tively (see fig. 1) 
b Results are expressed a  r sidues/molecule; data <0.1 are 
not given 
c The reduced recovery of the NH2-terminal mino acid s
due to the fluorescamine staining (see fig.l) 
cule could thus be accounted for. Comparison of the 
amino acid compositions of the EF-TuA R peptides 
with those of wild-type peptides revealed that the ala- 
nine residue in T46 from EF-TuAsB S is replaced by 
threonine in T46 from EF-TuA R (table 1). Such a 
replacement agrees in the finding [22] that EF-TuAsB S 
and EF-TuA R do not differ in isoelectric point and 
with the equal position of T46 in the corresponding 
fingerprints (fig.l). Dansyl-Edman degradation of 
mutant T46 yielded the sequence Phe-Thr- I le-Arg.  
It is concluded that position 375 in EF-TuA R is occu- 
pied by threonine. 
3.2. Methylation of lysine residue 56 
Several authors [13,14,28,29] have reported that 
Lys-56 could be methylated and that the extent of 
modification varied among the preparations. Fig.1 
shows that peptides T9 (residues 45-56) and T11 
(residues 57-58), which are clearly visible in the fin- 
gerprints of EF-TuA R, have almost vanished entirely 
from the prints of the wild-type factor. On the other 
hand peptide T10 (residues 45-58) is conspicuous in
the latter fingerprint, but barely visible in that of 
EF-TuA R. Amino acid analysis of wild-type T10 
showed the presence of mainly e-N,N-dimethyl-lysine 
and the virtual absence of lysine. Trypsin only hydrol- 
yzes the peptide bond between the residues 56 and 57 
when Lys-56 is not methylated. In EF-TuA R peptide 
T10 is almost completely fragmented, giving rise to 
T9 and T11 (fig.l). In this case only 15% of Lys-56 
appeared to be methylated to e-N-methyl-lysine. 
e-N,N-Dimethyl-lysine was completely absent in 
EF-TuA R. 
In another preparation of EF-TuAsB S (isolated 
from the Q13 strain ofE. coli) we exclusively found 
non-methylated lysine at position 56 (not shown). 
The two preparations of EF-TuAsB S with 0% and 
100% e-N,N-dimethyl-lysine w re found to be equally 
active in sustaining polypeptide synthesis in vitro (not 
shown). 
3.3. The COOH-terminal amino acid residue 
Amino acid analysis of the COOH-terminal tryptic 
peptide T49 from EF-TuA R revealed the presence of 
valine, leucine and glycine. No serine was detected. 
This is in agreement with the fact that EF-TuA R is a 
single-gene product derived from tufA [10,11,22]. 
4. Discussion 
The codon corresponding with Ala-375 in both 
tufA and tufB is GCA [11,12]. Apparently the substi- 
tution of Ala-375 by Thr (ACA) is caused by a transi- 
tion (G-C ~ A-T),  in accordance with the fact that 
ethyl methane sulphonate was used originally for 
mutagenesis [10,30,31 ]. Probably the mutation of 
EF-TuA R is restricted to this transition although we 
have not analyzed the tryptic peptides T7, T14, T16, 
T18, T23 and T24 (cf. [14]), which could not beiden- 
tiffed on the peptide map of fig.1. Additional muta- 
tions, however, seem unlikely considering the fre- 
quency (10 -8 ) of spontaneous mutations of the tufA 
gene to kirromycin resistance in cells which arbour 
already a mutated tufB gene [10]. Similarly, strepto- 
mycin resistance inE. coli appeared by single amino 
acid substitutions [32]. 
X-Ray diffraction patterns at 4 A resolution of 
EF-TuA R • GDP crystals did not reveal differences of 
the unit cell and the symmetry as compared to the 
corresponding parameters of wild-type EF-Tu [33]. 
This means that the 2 molecules are very similar or if 
differences exist, they are very subtle. 
X-Ray diffraction studies of wild-type EF-Tu • GDP 
crystals in [34-36] have led to a tentative model in 
which two domains can be distinguished: a rather 
tight domain with considerable a-helical characteris- 
tics; and a less well defined domain separated from 
the tight domain by a cleft. The tight domain corn- 
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prises approximately residues 61-240 [38] and con- 
tains the nucleotide binding site [34,37,38] situated 
on its surface and opposite to the rest of  the molecule. 
Therefore a direct interaction between ucleotide and 
Ala-375 seems unlikely. 
The following data suggest that Ala-375 is located 
in a region, which is profoundly involved in the allo- 
steric control of  the EF-Tu molecule. Various authors 
have provided evidence that the NH2-terminal region 
contains abinding site for the acceptor stem of  amino- 
acyl-tRNA [35,39]. Upon binding Of kirromycin to 
the EF-Tu • GDP complex conformational changes 
can be monitored in this part of  the molecule by mea- 
suring an increased accessibility for tryptic cleavage at 
Arg-44, Lys-56 and Arg-58 [15]. Furthermore, the 
EF-Tu - GDP • kirromycin complex displays an 
enhanced affinity for aminoacyl-tRNA [18,23]. Con- 
formational alterations also become apparent in the 
nucleotide binding site on the tight domain when the 
antibiotic binds to EF-Tu: the binding affinities of 
GTP and GDP change [I 5,22,40] and GTP hydrolysis 
is induced [16,41,42]. On the other hand, replacement 
of GDP by GTP opens the aminoacyl-tRNA binding 
site [1,2] and alters the conformation around resi- 
dues 44, 56 and 58 in a way very similar to that 
observed after kirromycin binding [ 15]. Presumably, 
movement of the 2 major domains relative to each 
other alters the orientation of the NHz-terminal region 
significantly. If so, this would implicate that the cleft 
between the two domains is involved in the alllosteric 
effect by kirromycin. Substitution of  Ala-375 by Thr 
reduces the affinity of  EF-Tu for the antibiotic by 
~2 orders of  magnitude [ 17,22,23 ]. Steric hindrance 
could be responsible for this reduction in affinity. 
Another possibility is that the amino acid replacement 
primarily affects the allosteric hanges accompanying 
for kirromycin binding. It is tempting to speculate 
that the allosteric site in which Ala-375 may be located 
in fact is in the cleft between the two domains of  
EF-Tu, but crystallographic data have to be awaited 
before such a suggestion can be substantiated. 
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